Evidence map›Paper›PMID 31554973›Full record

ArticleNature2019

FHL1 is a major host factor for chikungunya virus infection.

Laurent Meertens, Mohamed Lamine Hafirassou, Thérèse Couderc, Lucie Bonnet-Madin, Vasiliya Kril, Beate M Kümmerer, Athena Labeau, Alexis Brugier, Etienne Simon-Loriere, Julien Burlaud-Gaillard and 16 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 94 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. The SMARCA4-TMEM47 axis plays an essential role in chikungunya virus RNA replication.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Infectomics of Chikungunya Virus: Roles Played by Host Factors.The American journal of tropical medicine and hygiene · 2025
    Review
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 14 institutions in 2 countries.

Laurent Meertens *INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France. laurent.meertens@inserm.fr.
Mohamed Lamine HafirassouINSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Thérèse CoudercInstitut Pasteur, Inserm U1117, Biology of Infection Unit, Paris, France.
Lucie Bonnet-MadinINSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Vasiliya KrilINSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Beate M KümmererInstitute of Virology, University of Bonn Medical Centre, Bonn, Germany.
Athena LabeauINSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Alexis BrugierINSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Etienne Simon-LoriereInstitut Pasteur, G5 Evolutionary Genomics of RNA Viruses, Paris, France.
Julien Burlaud-GaillardINSERM U1259 MAVIVH et Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHRU de Tours, Tours, France.
Cécile DoyenInstitut de Génétique Humaine, Laboratoire de Virologie Moléculaire, CNRS-Université de Montpellier, Montpellier, France.
Laura PezziUnité des Virus Émergents, Aix-Marseille Univ, IRD190, Inserm 1207, EFS-IRBA, Marseille, France.
Thibaud GoupilInstitut Pasteur, Inserm U1117, Biology of Infection Unit, Paris, France.
Sophia RafasseInstitut Pasteur, Inserm U1117, Biology of Infection Unit, Paris, France.
Pierre-Olivier VidalainEquipe Chimie & Biologie, Modélisation et Immunologie pour la Thérapie, Université Paris Descartes, CNRS UMR 8601, Paris, France.
Anne Bertrand-LegoutCenter of Research in Myology, Sorbonne Université, INSERM UMRS974, Paris, France.
Lucie GueneauCenter of Research in Myology, Sorbonne Université, INSERM UMRS974, Paris, France.
Raul Juntas-MoralesDépartement de Neurologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
Rabah Ben YaouCenter of Research in Myology, Sorbonne Université, INSERM UMRS974, Paris, France.
Gisèle BonneCenter of Research in Myology, Sorbonne Université, INSERM UMRS974, Paris, France.
Xavier de LamballerieUnité des Virus Émergents, Aix-Marseille Univ, IRD190, Inserm 1207, EFS-IRBA, Marseille, France.
Monsef BenkiraneInstitut de Génétique Humaine, Laboratoire de Virologie Moléculaire, CNRS-Université de Montpellier, Montpellier, France.
Philippe RoingeardINSERM U1259 MAVIVH et Plateforme IBiSA de Microscopie Electronique, Université de Tours et CHRU de Tours, Tours, France.
Constance DelaugerreINSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France.
Marc LecuitInstitut Pasteur, Inserm U1117, Biology of Infection Unit, Paris, France.
Ali Amara *INSERM U944, CNRS UMR 7212, Genomes & Cell Biology of Disease Unit, Institut de Recherche Saint-Louis, Université de Paris, Hôpital Saint-Louis, Paris, France. ali.amara@inserm.fr.
Hôpital Saint-Louis · FRInserm · FRCentre National de la Recherche Scientifique · FRInstitut Pasteur · FRUniversité de Tours · FRAix-Marseille Université · FRBiology of Infection · FRCentre de Recherche en MyologieCentre Hospitalier Universitaire de Montpellier · FRLaboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques · FRSorbonne Université · FRUniversité de Montpellier · FRUniversité Paris Cité · FRUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is a re-emerging alphavirus that is transmitted to humans by mosquito bites and causes musculoskeletal and joint pain

Indexed as

Host-Pathogen InteractionsAnimalsCells, CulturedChikungunya FeverChikungunya virusFemaleFibroblastsHEK293 CellsHost-Derived Cellular FactorsHumansIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMaleMiceMuscle ProteinsMyoblastsFHL1 protein, humanHost-Derived Cellular FactorsIntracellular Signaling Peptides and ProteinsLIM Domain ProteinsMuscle Proteinsnsp3 protein, alphavirusRNA, ViralViral Nonstructural Proteins

Identifiers

PMID31554973
OpenAlexW2977027474

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.